Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ethicon Gains PMA For SEDASYS; Opens New Opportunity In GI Medicine

Executive Summary

Ethicon finally received FDA approval in May for its SEDASYS System, a computer-assisted personalized sedation system that allows physician-led teams to safely administer the anesthetic agent propofol during certain gastroenterology procedures, including colonoscopy. The approval opens up a whole new product category for the company with a market potential of 15 million procedures in the US alone.

Advertisement

Related Content

Six Devices, Diagnostics Among Cleveland Clinic’s Top 10 Innovations For 2014
Six Devices, Diagnostics Among Cleveland Clinic’s Top 10 Innovations
J&J Gets Second Chance At Sedasys Sedation Device Approval

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel